Dachaigh › Scleroderma › Illinois › Chicago
Sgrùdaidhean clionaigeach Scleroderma ann an Chicago, IL
Tha 10 sgrùdaidhean airson Scleroderma a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
A’ fastadhÌre 3
- Northwestern University, Chicago
- The University of Chicago Medical Center, Chicago
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
A’ fastadhÌre 2
- University of Illinois Health Outpatient Care Center, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
A’ fastadhÌre 1
- The University of Chicago Medical Center, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
A’ fastadhÌre 2/3
- GSK Investigational Site, Chicago
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
A’ fastadhÌre 1
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Platform Clinical Study for Conquering Scleroderma
A’ fastadhÌre 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
A’ fastadhÌre 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
A’ fastadhÌre 1/2
- Nkarta Investigational Site, Chicago
A Study of AZD0120 in Autoimmune Diseases
A’ fastadhÌre 1
- Research Site, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
A’ fastadhÌre 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Sgrùdaidhean Scleroderma ann am bailtean eile
- New York City, NY11 sgrùdadh
- Ann Arbor, MI10 sgrùdaidhean
- Houston, TX9 sgrùdaidhean
- Boston, MA7 sgrùdaidhean
- Los Angeles, CA7 sgrùdaidhean
- Durham, NC7 sgrùdaidhean
- New Orleans, LA6 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Baltimore, MD6 sgrùdaidhean
- Dallas, TX5 sgrùdaidhean
- Pittsburgh, PA5 sgrùdaidhean
- Miami, FL4 sgrùdaidhean
Sgrùdaidhean eile ann an Chicago
- Aillse Sgamhain Neo-chealla-beag61 sgrùdaidhean
- Aillse a' bhroilleach59 sgrùdaidhean
- Aillse (gach seòrsa)51 sgrùdaidhean
- Ailse metastatach45 sgrùdaidhean
- Aillse Prostata45 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Obesity41 sgrùdaidhean
- Cancer Ovarian36 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Buailteach34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ro-throm29 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.